Surfactant therapies for pediatric and neonatal ARDS: ESPNIC expert consensus opinion for future res...
Surfactant therapies for pediatric and neonatal ARDS: ESPNIC expert consensus opinion for future research steps
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Pediatric (PARDS) and neonatal (NARDS) acute respiratory distress syndrome have different age-specific characteristics and definitions. Trials on surfactant for ARDS in children and neonates have been performed well before the PARDS and NARDS definitions and yielded conflicting results. This is mainly due to heterogeneity in study design reflecting...
Alternative Titles
Full title
Surfactant therapies for pediatric and neonatal ARDS: ESPNIC expert consensus opinion for future research steps
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b1d7a7a7bde940429e33fe783eb457c6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b1d7a7a7bde940429e33fe783eb457c6
Other Identifiers
ISSN
1364-8535,1466-609X
E-ISSN
1364-8535,1466-609X,1366-609X
DOI
10.1186/s13054-021-03489-6
